Tomocube adds to its Global Distributor Network

Tomocube has taken steps to enhance the global support available to users of its holotomography microscopes during the continuing COVID-19 pandemic with the appointment of additional distributors.

European support in the Czech Republic and Slovakia will now be offered by SVEN BioLabs s.r.o. while a new primary distributor in Japan, Shinkou Seiki Co. Ltd., will manage and expand the existing dealer network.

According to Aubrey Lambert, Tomocube’s Chief Marketing Officer, “I am delighted to welcome Shinkou Seiki and SVEN BioLabs to our comprehensive global network of specialist imaging companies.

Representing some of the world’s finest microscopy and imaging companies, this 26-strong group supports the sales and maintenance of Tomocube’s unique holotomography microscopes in North America, Europe, and Australasia. Each has invested significantly in demonstration facilities that are at the disposal of researchers and scientists whenever the specific Covid-related guidance of individual countries allows.

The expansion of our support network is vital given the welcome that major life science research and diagnostic facilities around the world have given to our HT-1 and HT-2 holotomography microscopes, which overcomes many of the current limitations facing cellular analysis. I expect to be able to announce further additions to the network over the next months and the full list will always be found at”


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tomocube Inc.. (2020, August 04). Tomocube adds to its Global Distributor Network. News-Medical. Retrieved on June 04, 2023 from

  • MLA

    Tomocube Inc.. "Tomocube adds to its Global Distributor Network". News-Medical. 04 June 2023. <>.

  • Chicago

    Tomocube Inc.. "Tomocube adds to its Global Distributor Network". News-Medical. (accessed June 04, 2023).

  • Harvard

    Tomocube Inc.. 2020. Tomocube adds to its Global Distributor Network. News-Medical, viewed 04 June 2023,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Tomocube’s HT-2 microscope quantifies therapeutic effects of targeted nanodrugs against atherosclerosis